⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIVI News
BioVie, Inc. Common Stock
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
globenewswire.com
BIVI
Form 8-K
sec.gov
BIVI
BIVIW
BioVie Announces Update to Parkinson’s Phase 3 Development Program
globenewswire.com
BIVI
BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
globenewswire.com
BIVI
New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET
accessnewswire.com
VTIX
BIVI
First Phosphate and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
accessnewswire.com
BIVI
New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results
accessnewswire.com
BIVI
VTIX
COCH
LTRN
CAST
DVLT
IGC
BSIN
Join Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results
accessnewswire.com
BIVI
Form 8-K
sec.gov
BIVIW
BIVI
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
globenewswire.com
BIVI